Programme(s) to which this project applies:
|☒ MPhil/PhD||☑ MRes[Med]||☑ URIS|
Antivirals and immunosuppressive drugs are treatment for COVID-19 but concerns remain on COVID-19 related drug adverse events. The aim of this research project is to assess the long-term effectiveness and safety of antivirals and immunosuppressants used among COVID-19 patients who were discharged from hospitals in Hong Kong. Investigated drugs will be corticosteroid, antivirals (remdesivir, molnupiravir, paxlovid) and antirheumatic agents.
Dr CKH Wong, Department of Pharmacology and Pharmacy
Dr Carlos Wong is the Assistant Professor of the Department of Pharmacology and Pharmacy & Department of Family Medicine and Primary Care. His current research interests are pharmacoepidemiology, and health services research, particularly retrospective administrative database research and cost-effectiveness analysis of health care interventions.
For more information or to express interest for this project, please email the supervisor or the specified contact point in the project description. Interested candidates are advised to enclose with your email:
Information on the research programme, funding support and admission documentations could be referenced online at the Research Postgraduate Admissions website. General admission enquiries should be directed to firstname.lastname@example.org.
HKUMed MBBS students interested in the Master of Research in Medicine (MRes[Med]) programme may visit the programme website for more information.
HKUMed UG students interested in the Undergraduate Research Internship Scheme (URIS) may visit the scheme’s website for more information.